Prediction of abnormal cervical lesion by preoperative inflammatory markers

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20240426004

Enrollment

152

Registered

2024-04-26

Start date

2018-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical intraepithelial neoplasia 3 or more (CIN3+) was highly concerned for cervical cancer development. Loop electrosurgical excision procedure (LEEP) was occasional performed for therapeutic or diagnostic purposes. Inflammatory markers were associated with CIN due to the inflammatory process Cervical cancer, CIN, LEEP, Inflammatory markers

Interventions

Patients who had less than CIN3 from LEEP specimen.,Patients who had CIN3 or more from LEEP specimen.

Screening,Screening

less than CIN3,CIN3 plus

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria incorporate patients with complete digital medical records, including pre-procedural complete blood count (CBC) results and follow-up data

Exclusion criteria

Exclusion criteria: Exclusion occurs with patients with incomplete data, no pre-operative laboratory investigations, or missing follow-up records

Design outcomes

Primary

Measure	Time frame
CIN3 plus prediction 60 months of patient's data review Hosmer-Lemeshow goodness-of-fit test	—

Secondary

Measure	Time frame
N/A N/A N/A	—

Countries

Thailand

Contacts

Public ContactThapanop Thanasomthopchanamon

Thammasat University hospital

doctorthapanop@gmail.com639659646

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026